Y-mAbs

-$0.46 (-1.35%) As of 7:28 PM UTC today

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell Y-mAbs and other ETFs, options, and stocks.

About YMAB

Y-mAbs Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which focuses on the development and commercialization of antibody based therapeutic products for the treatment of cancer. Its services include discovery, protein engineering, clinical and regulatory.

CEO
Claus Juan Møller-San Pedro
Employees
125
Headquarters
New York, New York
Founded
2015

YMAB Key Statistics

Market Cap
1.61B
Price-Earnings Ratio
—
Dividend Yield
—
Average Volume
264.69K
High Today
$35.67
Low Today
$33.24
Open Price
$34.07
Volume
141.47K
52 Week High
$55.22
52 Week Low
$24.78

YMAB Earnings

-$1.01
-$0.42
$0.16
$0.75
Q4 FY19
Q1 FY20
Q2 FY20
Q3 FY20
Q4 FY20
Q1 FY21
Q2 FY21
Estimated
— per share
Actual
Expected Aug 5, After Hours
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC. Full disclosure